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cocultured for ﬁve days and after separation analysed for the presence
of typical MSC markers and Treg markers by FACS. Single MSC and
Treg+MLC cultures were used as controls. IL-2, 4, 6, 10, 17a, IFN-g and
TNF were assessed after 2 and 5d of cocultivation by cytometric bead
array (CBA) analysis.
In a second step, Treg+MLC cultures were analyzed in the presence of
IL-6-complemented media with varying concentrations and media taken
from MSC cultures (DMEM-LG). The abundance of IL-6 in these culture
conditions was veriﬁed at different time points by CBA analysis.
Results: Both MSC from BM and SMwere able to maintain the percentage
of Tregs in coculture, while in Treg+MLC without addition of MSC, there
was a signiﬁcant decrease of the Treg fraction after 5 days. The effect of
Treg maintenance was independent from Treg/MSC ratio. Compared to
MSC cultures alone, T-cell-MSC cocultures showed a signiﬁcant increase
in IL-6 abundance after 2 and 5 days of culture. Cocultivation with MSC
taken from synovial membrane showed signiﬁcantly higher amounts of
IL-6 production compared to BM-MSC-T-cell cocultures. Cultured without
T-cells, SM-derived MSC showed a higher IL-6 production than BM-
MSC. Overall IL-6 production was signiﬁcantly reduced after 5 days of
coculture, compared to the amounts observed at day 2. However, the
differences between SM- and BM-MSC remained signiﬁcant.
The effect of Treg maintenance could be replicated by IL-6 addition to
culture media in a dose-dependent way. However, Treg maintenance was
highest with media taken from MSC cultures, even if the abundance of
IL-6 found in these media was surmounted in naive DMEM-LG. IL-2, 4,
10, 17a, IFN-g and TNF-concentrations showed no signiﬁcant differences
between these groups.
Conclusions: The immunogenic potential of MSC has already induced
certain therapeutic approaches in autoimmune diseases. Despite the
knowledge that MSC are potent regulators of T-cell function in various
diseases, their role in the modulation of osteoarthritis is mostly
unknown. It is known that MSC can regulate and recruit Tregs in vitro.
Our data clearly demonstrates that maintenance of Treg phenotype
in MSC-T-cell cocultures can be mediated by MSC derived from
osteoarthritis patients. IL-6 seems to play an important role in mediating
these processes. However, other soluble factors secreted by MSC can be
supposed to regulate T-cell and Treg function more speciﬁcally. We
postulate that synovial inﬂammation is responsible for the signiﬁcant
differences in IL-6 secretion by MSC derived from synovial membrane
and bone marrow. However, this does not seem to affect MSC potency
to maintain the Treg phenoytype.
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MORE INFLAMMATORY SIGNS ON ULTRASOUND IN
INTERPHALANGEAL JOINTS IN EROSIVE HAND OSTEOARTHRITIS
M. Kortekaas, W-Y. Kwok, M. Reijnierse, T. Huizinga, M. Kloppenburg.
Leiden Univ. Med. Ctr., Leiden, Netherlands
Purpose: Erosive hand osteoarthritis (EOA) is a subset of hand
osteoarthritis (HOA) associated with a higher clinical burden than non-
erosive disease. The processes that lead to erosive evolution are still
unknown. The clinical course of EOA is characterised by episodes of
inﬂammatory signs, as assessed during physical examination. Recent
ultrasound (US) studies demonstrated a high incidence of inﬂammatory
signs in both HOA and EOA.
In the present study the presence of inﬂammatory signs assessed by US
in erosive and non-erosive interphalangeal joints in patients with EOA
in comparison to interphalangeal joints from patients with non-erosive
HOA was investigated.
Methods: Of 55 consecutive HOA patients, fulﬁlling the ACR criteria,
at least 45 years of age, interphalangeal joints from both hands were
studied. Conventional radiographs of both hands were scored according
to Verbruggen and Veys; E(rosive) and R(emodeled)-phases were deﬁned
as erosive. Using US all 18 interphalangeal hand joints were scored for
synovial thickening, effusion, greyscale (GS) synovitis, and Power Doppler
Signal (PDS) on a four-point scale.
Generalized estimated equation (GEE) analyses were performed to
study the association between inﬂammatory signs and erosiveness in
individual joints. GEE was also performed to study the association
between the N(ormal), S(tationary), J(oint space loss), E and R-phases
and US inﬂammatory signs. Relative risks were presented as odds ratios
(OR) with 95% conﬁdence intervals (95% CI). In multivariate analyses
adjustments were made for confounders (age, sex and BMI).
Results: Of 55 HOA patients (mean age 61 years, 86% females) 51%
showed at least one erosive joint. In 94 erosive joints GS synovitis,
synovial thickening, effusion and PDS were found in 57%, 13% 50% and
15%, respectively; in 896 non-erosive joints in 29%, 10%, 26% and 8%,
respectively. Summated scores of PDS, GS synovitis and effusion were
higher in EOA than in non-erosive HOA. GS synovitis was more frequent
in S, J, E and R-phases compared to N-phases. PDS was only associated
with E-phase (5.3 (1.3–20.5)) not with other phases. Non-erosive joints in
EOA demonstrated more PDS (3.2 (1.6–6.4)), GS synovitis (2.2 (1.3–3.7))
and effusion (2.2 (1.2–3.8)) in comparison to joints in non-erosive HOA.
Conclusions: Inﬂammatory signs are more frequent in EOA than
in non-erosive HOA, especially in the erosive joints. Remarkably,
also interphalangeal joints without erosions in patients with EOA
demonstrated more inﬂammatory US signs in comparison to
interphalangeal joints of patients with non-erosive HOA. These results
suggest an underlying systemic cause for erosive evolution.
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WITH MUSCLE CO-ACTIVATION: A COMMON MECHANISM AFFECTING
PAIN AND FUNCTION IN KNEE OA?
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Purpose: Deep somatic pain decreases agonist and increases antagonist
activity during dynamic muscle activity (pain adaptation theory).
Muscle co-activation (antagonistic hamstring muscle activation during
quadriceps agonist activity) is of interest in knee OA because it may
increase joint stability on the one hand, but may contribute to worsening
structural lesions on the other. Experimental pain studies support central
mechanisms affecting muscle function, but whether this occurs in OA is
not known. This is relevant because knee OA is associated with peripheral
and central sensitization (nervous system alterations in pain signaling),
which in turn is associated with pain severity, but its association with
motor function changes is not known. We therefore examined whether
sensitization is associated with altered motor activity in knee OA as
assessed by muscle co-activation.
Methods: The MOST Study is a NIH-funded cohort of persons with or
at risk of knee OA. We obtained surface EMG of the medial and lateral
quadriceps and hamstrings during knee extension and ﬂexion maximum
voluntary contractions (MVC) using an isokinetic dynamometer (Cybex)
at 60°/s. Hamstring muscle co-activation was deﬁned as the median
of 4 trials in a single limb of hamstring muscle EMG activity during
knee extension MVC, standardized by the peak hamstring EMG levels
during knee ﬂexion MVC (% of max). Medial and lateral hamstring
muscles were considered separately and combined as overall hamstring
co-activation (using a root mean square approach) as our outcomes. Our
two sensitization exposures were assessed in the same limb as hamstring
co-activation: (1) Temporal summation (augmented pain response to
repetitive mechanical stimuli; a marker of central sensitization) was
deﬁned as being present when, after touching the skin over the patella
with a 60 g monoﬁlament repeatedly at 1Hz for 30 s, the subject
reported new or increased pain at the patella. (2) Pressure pain threshold
(PPT) is a marker of peripheral +/− central sensitization at sites of
disease/inﬂammation, or of central sensitization when assessed at an
otherwise normal area. PPT was assessed with an algometer (1 cm2
tip) at the patella as the point at which the participants indicated
that the pressure ﬁrst changed to slight pain. The average of 3 trials
was used to calculate the PPT. Because muscle co-activation was not
normally distributed, we categorized it into age- and sex-speciﬁc tertiles
to evaluate the relation between sensitization and muscle coactivation
with a generalized logistic model.
Results: 1633 participants had data from the surface EMG and
sensitization assessments (mean age 67.3±7.7, mean BMI 30.3±5.6, 58%
female, 39% with tibiofemoral OA). Temporal summation was present in
40%. The median (IQR) for PPT was 4.9 (3.6–6.6) kg/cm2, and for overall
hamstring co-activation was 10.1% (5.7–15.1). Temporal summation was
associated with ~30% greater odds of having the highest tertile of medial
and overall hamstring co-activation compared with the lowest tertile, but
not with lateral hamstring co-activation (Table). Low PPT (lowest tertile)
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was associated with greater odds of overall, medial, and nonsigniﬁcantly
with lateral hamstring co-activation compared with those in the highest
tertile (Table). Similar but mainly nonsigniﬁcant associations were noted
when limited to only those with radiographic knee OA. No associations
were noted for sensitization with the middle vs. lowest tertiles of muscle
co-activation.
Conclusions: In this initial evaluation, presence of sensitization as
assessed by temporal summation and lower PPT was generally associated
with greater hamstring co-activation during knee extension. This
provides support to the possibility that peripheral/central nervous
system alterations may not only affect pain sensitivity, but also motor
function.
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IDENTIFICATION AND DIFFERENT LOCALIZATION OF PROTEINS
IN THE SUPERFICIAL AND THE DEEP HUMAN OA CARTILAGE BY
IMAGING MASS SPECTROMETRY
B. Cillero-Pastor1, G. Eijkel1, A. Kiss1, F. Blanco2, R. Heeren1. 1AMOLF-FOM
Inst.. Netherlands Proteomics Ctr., Amsterdam, Netherlands; 2Osteoarticular
and Aging Res. Lab.. INIBIC-CHUAC, A Corun˜a, Spain
Purpose: The knowledge of the distribution and the modulation that
proteins suffer in the different phases of the rheumatic pathologies is
essential to understand the development of these diseases and to ﬁnd
the best targets for treatment. Imaging mass spectrometry (IMS) allows
us to study the spatial distribution of different components with a high
resolution, through a section of tissue. It permits also the identiﬁcation
of many proteins at the same time without labeling. In this study, we
have studied the localization of proteins associated with OA pathology in
different areas of normal and OA human cartilage by MALDI-imaging.
Methods: Human control and OA cartilage samples were cut in triplicate
obtaining 10mm thick sections and deposited on indium tin oxide
(ITO) high conductivity slides. For MALDI imaging experiments different
washing and enzymatic steps were performed. For imaging purposes
spots of trypsin were deposited by a high-accuracy position automatic
chemical inkjet printer. Alpha-Cyano-4-hydroxycinnamic acid matrix
(HCCA) was deposited by a vibrational sprayer system. A Synapt
HDMS MALDI-Q-TOF was used to perform the imaging-MS and MS/MS
experiments with a spatial resolution of 150mm. To perform the peptide
identiﬁcation, the Mascot algorithm was employed after proﬁling MS/MS
and imaging-MS/MS experiments. Biomap software was used to study
the localization and the intensity of the different peptides. Hematoxylin-
eosin staining was performed to complement the spatial information.
Principal component analysis (PCA) and discriminant analyses (DA) were
used for data interpretation.
Results: We have created speciﬁc peptide/protein maps in control and
OA cartilage slides identifying and localizing proteins by proﬁling MALDI-
MS/MS and imaging MS/MS experiments on tissue. For the ﬁrst time,
well known proteins such as Biglycan, Prolargin, Aggrecan core protein
or Decorin have been identiﬁed directly from the tissue with this
technique in the human control cartilage samples. In addition to this,
important OA biomarkers have been identiﬁed and localized. Different
peptides of Cartilage oligomeric matrix protein (COMP) (m/z 1613.83,
2256.15), Fibronectin (m/z 1349.72, 1401.71, 1591.87, 1913.03) or Cartilage
intermediate layer protein 1 (CILP1) (m/z 1954.00) were found in the OA
tissues. MS/MS experiments of digested peptides in solution conﬁrmed
these results. After normalizing the intensity of these peaks using the
Biomap software, we observed that the presence of these peptides was
higher in OA than in normal samples as we expected. Interestingly, their
distribution seemed to be more evident in the deep cartilage than in the
superﬁcial area. By means of PCA and DA analyses between control and
OA groups we created a list of peaks that differentiate OA samples. The
larger part of these OA-related peaks, were localized again in the deep
area.
Conclusions: We have localized and identiﬁed proteins in normal and
OA human cartilage by MALDI-imaging. Classical biomarkers of OA are
mostly distributed in the deep area. These results support that the cross-
talk between the cartilage and the bone could be relevant in the OA
development.
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HIGH ADAMTS4 OR 5 ACTIVITY AND SEVERE ARTICULAR CARTILAGE
AGGRECAN DEPLETION ONLY DO NOT LEAD TO OA IN YOUNG MICE
UNDER STANDARD LABORATORY CONDITIONS
P.M. van der Kraan1, F. Kolb2, E.L. Vitters1, S. Barbieri2, U. Bodendorf2,
N. Gerwin2, W.B. van den Berg1. 1Radboud Univ., Med. Ctr., Nijmegen,
Netherlands; 2Novartis Inst.s for BioMed. Res., Basel, Switzerland
Background: Joint diseases such as osteoarthritis (OA) result in
destruction of articular cartilage and loss of joint function. The main
structural components of articular cartilage are, besides water, type II
collagen and aggrecan. Aggrecan is considered the molecule responsible
for the load-resistant characteristics of cartilage. The two main enzymes
that degrade aggrecan are identiﬁed as ADAMTS4 (aggrecanase-1) and
ADAMTS5 (aggrecanase-2).
Purpose: We studied whether local over-expression of human ADAMTS4
or 5, only in the knee joint, was possible and if this resulted in OA
development.
Methods: Two unique transgenic mouse strains (Balb/c background)
that express inducible active ADAMTS4 or ADAMTS5 were developed.
These strains contain ﬂoxed human ADAMTS4 or ADAMTS5 genes and
transcription is only activated after tamoxifen exposure. Transgenic mice
and control littermates were injected in the right knee joint with
4-hydroxytamoxifen (4-HOT), highest dose 5 microgram/joint. Whole
knee joints of mice sacriﬁced at 2 and 42 days after 4-HOT injection
were sectioned and stained.
Results: Intra-articular injection of 4-HOT in ADAMTS transgenic mice
resulted in expression of ADAMTS, solely in the injected knee joint.
Injection of 4-HOT in control littermates did not lead to any observable
effect. In ADAMTS mice, on day 2 after 4-HOT injection, the articular
cartilage showed clear aggrecan loss. Loss of aggrecan progressed over
time and after 42 days severe aggrecan depletion was present in
the femoral-tibial and patella-femoral cartilage. In aggrecan-depleted
cartilage, a few chondrocytes were surrounded by an intensely safranin
O-stained halo. Remarkably, apart from aggrecan depletion no other
indication of pathology, such as inﬂammation or tissue damage, was
observed. Neither human ADAMTS expression nor aggrecan loss was seen
in any other joints of the 4-HOT injected mice. To our great surprise, no
structural sign of OA, such as surface ﬁbrillation or erosions, were present
in the severely aggrecan-depleted cartilage at day 42, although aggrecan
depletion in the knee joints of these mice was severe for weeks.
Conclusion: ADAMTS4 or 5 can be locally over-expressed in the knee
joint of inducible transgenic mice. This leads to severe aggrecan depletion
but not to development of OA-like cartilage lesions within 6 weeks.
Merely elevated ADAMTS activity and loss of aggrecan is not sufﬁcient
to induce damage in young mice. Apparently, an additional trigger,
damaging the collagen matrix such as increased loading, is essential
to cause OA in aggrecan-depleted cartilage in young ADAMTS4 and
ADAMTS5 transgenic mice under standard laboratory conditions.
